Insmed to Showcase Pioneering Phase 3 ASPEN Study Results at CHEST 2025 Insmed reveals key findings from the Phase 3 ASPEN trial on BRINSUPRI™ at CHEST 2025, focusing on efficacy for non-CF bronchiectasis.

Insmed to Showcase Pioneering Phase 3 ASPEN Study Results at CHEST 2025 #United_States #Chicago #Insmed #Brinsupri #CHEST_2025

Trevi Therapeutics Unveils Exciting Research at CHEST 2025 Meeting Trevi Therapeutics is set to showcase its groundbreaking research at the CHEST 2025 Annual Meeting, focusing on chronic cough treatments in pulmonary fibrosis patients.

Trevi Therapeutics Unveils Exciting Research at CHEST 2025 Meeting #United_States #Chicago #Trevi_Therapeutics #nalbuphine_ER #CHEST_2025